Profile | GDS4284 / 238777_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 221.555 | 51 |
GSM687648 | Patient 402 control | 238.306 | 52 |
GSM687653 | Patient 403 control | 204.161 | 50 |
GSM687658 | Patient 404 control | 329.223 | 57 |
GSM687663 | Patient 411 control | 224.831 | 50 |
GSM687668 | Patient 422 control | 244.813 | 52 |
GSM687673 | Patient 424 control | 215.487 | 48 |
GSM687678 | Patient 425 control | 259.911 | 52 |
GSM687683 | Patient 427 control | 303.976 | 54 |
GSM687688 | Patient 428 control | 224.078 | 51 |
GSM687695 | Patient 441 control | 400.571 | 56 |
GSM687699 | Patient 443 control | 438.532 | 60 |
GSM687704 | Patient 444 control | 281.904 | 55 |
GSM687707 | Patient 448 control | 259.929 | 51 |
GSM687712 | Patient 449 control | 303.093 | 55 |
GSM687719 | Patient 450 control | 380.785 | 58 |
GSM687724 | Patient 451 control | 283.914 | 54 |
GSM687728 | Patient 452 control | 159.713 | 42 |
GSM687646 | Patient 401 treated 24h | 373.472 | 58 |
GSM687649 | Patient 402 treated 24h | 258.35 | 54 |
GSM687665 | Patient 411 treated 24h | 401.236 | 59 |
GSM687651 | Patient 402 treated 4 weeks | 269.719 | 53 |
GSM687667 | Patient 411 treated 4 weeks | 307.005 | 55 |
GSM687670 | Patient 422 treated 24h | 301.737 | 55 |
GSM687671 | Patient 422 treated 4 weeks | 248.937 | 53 |
GSM687654 | Patient 403 treated 24h | 153.445 | 45 |
GSM687675 | Patient 424 treated 24h | 264.078 | 52 |
GSM687685 | Patient 427 treated 24h | 215.174 | 49 |
GSM687656 | Patient 403 treated 4 weeks | 220.485 | 52 |
GSM687677 | Patient 424 treated 4 weeks | 234.426 | 51 |
GSM687687 | Patient 427 treated 4 weeks | 184.005 | 48 |
GSM687692 | Patient 428 treated 4h | 287.068 | 55 |
GSM687716 | Patient 449 treated 4h | 267.82 | 54 |
GSM687722 | Patient 450 treated 4h | 399.156 | 59 |
GSM687680 | Patient 425 treated 24h | 253.482 | 52 |
GSM687690 | Patient 428 treated 24h | 288.59 | 56 |
GSM687700 | Patient 443 treated 24h | 572.484 | 63 |
GSM687705 | Patient 444 treated 24h | 219.926 | 52 |
GSM687714 | Patient 449 treated 24h | 204.25 | 50 |
GSM687721 | Patient 450 treated 24h | 404.733 | 58 |
GSM687682 | Patient 425 treated 4 weeks | 240.344 | 53 |
GSM687694 | Patient 428 treated 4 weeks | 262.032 | 54 |
GSM687702 | Patient 443 treated 4 weeks | 363.833 | 57 |
GSM687718 | Patient 449 treated 4 weeks | 290.54 | 55 |
GSM687723 | Patient 450 treated 4 weeks | 371.332 | 59 |
GSM687661 | Patient 404 treated 4h | 272.297 | 53 |
GSM687710 | Patient 448 treated 4h | 285.489 | 55 |
GSM687726 | Patient 451 treated 4h | 232.548 | 49 |
GSM687730 | Patient 452 treated 4h | 702.865 | 65 |
GSM687660 | Patient 404 treated 24h | 286.569 | 52 |
GSM687697 | Patient 441 treated 24h | 296.66 | 51 |
GSM687709 | Patient 448 treated 24h | 233.049 | 50 |
GSM687725 | Patient 451 treated 24h | 336.292 | 55 |
GSM687729 | Patient 452 treated 24h | 270.616 | 49 |
GSM687727 | Patient 451 treated 4 weeks | 33.3062 | 15 |
GSM687731 | Patient 452 treated 4 weeks | 213.101 | 47 |